SeaCrest Wealth Management LLC Sells 2,187 Shares of Unilever PLC (NYSE:UL)

SeaCrest Wealth Management LLC lessened its stake in Unilever PLC (NYSE:UL) by 13.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,361 shares of the company’s stock after selling 2,187 shares during the period. SeaCrest Wealth Management LLC’s holdings in Unilever were worth $700,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Citigroup Inc. raised its position in shares of Unilever by 51.1% during the 3rd quarter. Citigroup Inc. now owns 672,859 shares of the company’s stock valued at $33,239,000 after acquiring an additional 227,681 shares during the last quarter. Deutsche Bank AG raised its position in shares of Unilever by 3.4% during the 3rd quarter. Deutsche Bank AG now owns 47,772 shares of the company’s stock valued at $2,360,000 after acquiring an additional 1,589 shares during the last quarter. St. James Investment Company LLC raised its position in shares of Unilever by 11.3% during the 3rd quarter. St. James Investment Company LLC now owns 733,123 shares of the company’s stock valued at $36,216,000 after acquiring an additional 74,539 shares during the last quarter. ProVise Management Group LLC raised its position in shares of Unilever by 12.3% during the 3rd quarter. ProVise Management Group LLC now owns 131,494 shares of the company’s stock valued at $6,496,000 after acquiring an additional 14,404 shares during the last quarter. Finally, Sei Investments Co. raised its position in shares of Unilever by 1.6% during the 3rd quarter. Sei Investments Co. now owns 394,801 shares of the company’s stock valued at $19,505,000 after acquiring an additional 6,341 shares during the last quarter. Institutional investors own 9.67% of the company’s stock.

Analysts Set New Price Targets

UL has been the subject of several recent research reports. Jefferies Financial Group cut shares of Unilever from a “buy” rating to an “underperform” rating in a research report on Monday, December 11th. StockNews.com upgraded shares of Unilever from a “hold” rating to a “buy” rating in a research note on Wednesday, March 20th. Morgan Stanley downgraded shares of Unilever from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $52.00 to $48.00 in a research note on Tuesday, February 27th. Finally, Sanford C. Bernstein raised shares of Unilever from an “underperform” rating to a “market perform” rating in a report on Monday, December 11th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $48.00.

Unilever Stock Performance

NYSE:UL traded up $0.05 during mid-day trading on Friday, reaching $50.19. The stock had a trading volume of 1,290,277 shares, compared to its average volume of 2,628,611. The stock has a 50-day simple moving average of $49.37 and a two-hundred day simple moving average of $48.75. Unilever PLC has a 12 month low of $46.16 and a 12 month high of $55.99.

Unilever Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd were paid a dividend of $0.4582 per share. The ex-dividend date was Thursday, February 22nd. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.65%.

About Unilever

Unilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products, which includes the vitamins, minerals, and supplements.